Cardinal Health earnings per share down 16 percent in quarter
NEW YORK Cardinal Health reported today that its earnings for the first quarter 2009 were down by 16 percent from the same quarter last year. Cardinal’s earnings totalled $249 million, or 69 cents per share, against $302 million, or 82 cents per share, for the first quarter 2008, the company said.
The company also reported that its earnings were 74 cents per share for first quarter 2009, before consideration of impairments, which reduced earnings 5 cents per share.
The company reported that its total revenue increased to $24.35 billion, up compared to $21.97 billion last year.
Analysts have said that Cardinal’s guidance range for the year has stayed the same at a rate of $3.80 to $3.95 per share for non-GAAP (based on data other than what’s generally accepted) earnings, from continuing operations, reports said.
Medimetriks announces agreement to market treatments for impetigo
FAIRFIELD, N.J. Medimetriks Pharmaceuticals has entered into a licensing agreement with Perrigo for U.S. Marketing rights to Centany Ointment and two prescription keratolytic brands, Medimetriks announced Tuesday.
Johnson & Johnson’s OrthoNeutrogena professional division previously marketed Centany, which is used for treating impetigo caused by Straphylococcus aureas and Streptococcus pyogenes bacteria. The Food and Drug Administration approved it in 2002.
The two keratolytic brands are urea-based therapies for treating severe dry skin.
“We are happy to have a partner that brings such a record of success in the branded pharmaceutical business,” Perrigo executive vice president Sharon Kochan said in a statement. “We believe the licensed products are in good hands, given Medimetriks management’s proven abilities in building a successful business in the dermatology and podiatry markets.”
Few healthcare providers receive adequate training, tools to help patients quit smoking
NEW YORK A new study suggests that few healthcare workers have sufficient training in smoking cessation to help patients quit.
The study, presented Monday at the annual meeting of the American College of Chest Physicians in Philadelphia, found that 87 to 93 percent of healthcare providers receive less than five hours of smoking cessation training, while less than 6 percent know the governmental Agency for Healthcare Research and Quality’s guidelines for treating people with tobacco dependence.
The study surveyed 600 people working in health care, including physicians, nurse practitioners, pharmacists, social workers and students, and divided them into prescribers and non-prescribers.